Lightman James 4

Accession 0001235802-19-000133

CIK 0001492658other

View on SEC.gov Company Profile

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 4:22 PM ET

Size

44.2 KB

Accession

0001235802-19-000133

Insider Transaction Report

Form 4

Period: 2019-11-15

Wright Medical Group N.V.WMGI

Lightman James

SVP, General Counsel & Secty

Transactions

Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-15$15.75/sh+33,504$527,688→ 95,079 total
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-15$22.55/sh+1,999$45,077→ 105,088 total
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-15$29.06/sh+9,086$264,039→ 125,273 total
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-15$24.49/sh+7,284$178,385→ 250,443 total
Exercise/Conversion
Stock Option (right to buy)
2019-11-15−28,944→ 6,720 total
Exercise: $21.24Exp: 2026-07-19→ Ordinary Shares (28,944 underlying)
Exercise/Conversion
Stock Option (right to buy)
2019-11-15−7,284→ 16,035 total
Exercise: $24.49Exp: 2028-07-24→ Ordinary Shares (7,284 underlying)
Exercise/Conversion
Stock Option (right to buy)
2019-11-15−33,504→ 0 total
Exercise: $15.75Exp: 2021-12-29→ Ordinary Shares (33,504 underlying)
Exercise/Conversion
Stock Option (right to buy)
2019-11-15−78,785→ 0 total
Exercise: $20.62Exp: 2025-10-13→ Ordinary Shares (78,785 underlying)
Exercise/Conversion
Stock Option (right to buy)
2019-11-15−10,157→ 7,917 total
Exercise: $27.86Exp: 2027-07-25→ Ordinary Shares (10,157 underlying)
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-15$17.70/sh+566$10,018→ 95,645 total
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-15$23.93/sh+11,099$265,599→ 116,187 total
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-15$20.62/sh+78,785$1,624,547→ 204,058 total
Exercise/Conversion
Stock Option (right to buy)
2019-11-15−1,999→ 0 total
Exercise: $22.55Exp: 2023-04-17→ Ordinary Shares (1,999 underlying)
Exercise/Conversion
Stock Option (right to buy)
2019-11-15−11,099→ 0 total
Exercise: $23.93Exp: 2023-05-14→ Ordinary Shares (11,099 underlying)
Exercise/Conversion
Stock Option (right to buy)
2019-11-15−9,086→ 0 total
Exercise: $29.06Exp: 2024-05-13→ Ordinary Shares (9,086 underlying)
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-15$20.75/sh+7,444$154,463→ 103,089 total
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-15$21.24/sh+28,944$614,771→ 233,002 total
Exercise/Conversion
Stock Option (right to buy)
2019-11-15−566→ 0 total
Exercise: $17.70Exp: 2022-04-16→ Ordinary Shares (566 underlying)
Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-11-15$27.86/sh+10,157$282,974→ 243,159 total
Sale
Ordinary Shares, par value EUR 0.03 per share
2019-11-15$29.45/sh−188,868$5,562,503→ 61,575 total
Exercise/Conversion
Stock Option (right to buy)
2019-11-15−7,444→ 0 total
Exercise: $20.75Exp: 2022-05-09→ Ordinary Shares (7,444 underlying)

Footnotes (7)

[F1]Exercise and sale of vested stock options in connection with 280G tax planning.
[F2]Includes 3,103 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 9,580 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 10,124 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.40 to $29.495, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
[F4]This option has fully vested.
[F5]This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
[F6]This option vested with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
[F7]This option vested with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Wright Medical Group N.V.

CIK 0001492658

→

Entity typeother

Related Parties

filerCIK 0001317960

Filing Metadata

Form type: 4
Filed: Nov 17, 7:00 PM ET
Accepted: Nov 18, 4:22 PM ET
Size: 44.2 KB

View on SEC.gov